Medtronic Plc MDT

NYSE · Healthcare · Medical - Devices

$99.94

Close on Fri, 20 Nov 2026 · market value $128B

What the price is betting on

Below its record

At $100, the price assumes revenue grows about 1.4% a year for five years, from $37.5B to about $40.1B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes1.4%
Analysts, next two years4.2%
Last 3 years5.8%

Revenue growth a year. The price figure comes from a reverse DCF at a 7.6% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than MDT? Check up to 5 of your stocks at once, free, no account.

0$20B$40B$60B$37.5B'23'24'25'26Jul '26'27'28'29'30'31What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$106

Base

$118

Bull

$132

Today $100

  • Bear $106. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $118. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $132. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2027$37.9B$39B, on the path
  3. FY2028$38.5B$40.3B, on the path
  4. FY2029$39B$42.1B, on the path
  5. FY2030$39.5B$44.7B, on the path
  6. FY2031$40.1B$46B, on the path

Each year's revenue at 1.4% growth from $37.5B in the 12 months to July 2026.

At a glance

Healthcare · Medical - Devices · listed on NYSE

Revenue, FY2026
$36.4B
Growth, 3 years a year
5.8%
Cash margin
15%
Net debt
$18.7B
Shares, 3-year change
−4.7%
Dividend yield
2.8%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.